Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Healthy Johnson & Johnson Stock Going To $72
Forbes
Saturday, March 3, 2012 - 12:23pm
tags:
JNJ
Mylan Continues to Pursue Damages and Injunction Against Sunovion's Brovana in Ongoing Litigation
Sacramento Bee, CA
Saturday, March 3, 2012 - 12:22pm
tags:
Mylan, Sunovion, Brovana, lawsuit, Patent Infringement
Sector Snap: Generic competition and biotech drugs
CBS News
Saturday, March 3, 2012 - 12:19pm
tags:
biogenerics, generics
SK Biopharmaceuticals Drug Program Wins Funding Support from Korean Government
BusinessWire
Saturday, March 3, 2012 - 12:17pm
tags:
SK Biopharmaceuticals, YKP3089, epilepsy
Is Teva considering a jump to NYSE?
FiercePharma
Saturday, March 3, 2012 - 11:43am
tags:
Teva Pharmaceuticals
State court (CA) to examine ‘pay-for-delay’ deals by drugmakers
U-T San Diego, CA
Saturday, March 3, 2012 - 11:42am
tags:
generics, legal
India's Dr. Reddy's get U.S. nod for schizophrenia capsules
Reuters
Saturday, March 3, 2012 - 11:40am
tags:
Dr Reddy's, schizophrenia, Geodon, generics
FDA Delays Eliquis Verdict
Yahoo/Zacks
Saturday, March 3, 2012 - 11:39am
tags:
Eliquis, Bristol-Myers Squibb, Pfizer, anti-clotting
BSX Unveils Promus Element in Japan
Yahoo/Zacks
Saturday, March 3, 2012 - 11:34am
tags:
Boston Scientific, Abbott Laboratories
Abbott Labs Doing Deals, Stock Headed To $62
Forbes
Saturday, March 3, 2012 - 11:33am
tags:
Abbott Laboratories
Why Some Trends Matter, Even When There Is A Hiccup
Seeking Alpha
Saturday, March 3, 2012 - 11:32am
tags:
R&D
JP Morgan analyst upgrades Eli Lilly to 'Neutral'
Yahoo/AP
Saturday, March 3, 2012 - 11:31am
tags:
Eli Lilly
Pfizer Is A Better Buy For Longer-Term Investors
Seeking Alpha
Saturday, March 3, 2012 - 11:30am
tags:
Pfizer
GlaxoSmithKline Antitrust Probe Dropped by EU Commission
Bloomberg
Saturday, March 3, 2012 - 11:29am
tags:
GSK, antitrust
We Think Pfizer Is Ridiculously Cheap
Seeking Alpha
Saturday, March 3, 2012 - 11:24am
tags:
Pfizer
Isis Loss Widens; Focus on Kynamro
Yahoo/Zacks
Saturday, March 3, 2012 - 11:24am
tags:
Isis Pharmaceuticals, Kynamro, Genzyme, Sanofi
Watson launches generic version of Abbott's Prometrium
Yahoo/theflyonthewall.com
Saturday, March 3, 2012 - 11:22am
tags:
Watson Pharmaceuticals, Prometrium, generics
FDA Approval Practically A Done Deal For Keryx And AEterna Zentaris
Seeking Alpha
Saturday, March 3, 2012 - 11:20am
tags:
Keryx, Aeterna Zentaris, perifosine
Roche's Illumina Bid Gets More Time
Yahoo/Zacks
Saturday, March 3, 2012 - 11:17am
tags:
Roche, Illumina, M&A
IBD Tech Stock Screen: 5 Top Meds Start With Questcor
Investors.com
Saturday, March 3, 2012 - 11:15am
tags:
Questcor Pharmaceuticals, Alexion, Celgene, ViroPharma, Cubist Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.